Trademark: 79052271
Word

Status
Registered
Status Code
706
Status Date
Tuesday, April 2, 2019
Serial Number
79052271
Registration Number
3502080
Registration Date
Tuesday, September 16, 2008
Mark Type
2
Filing Date
Wednesday, July 25, 2007
Published for Opposition
Tuesday, July 1, 2008

Trademark Owner History
Genmab A-S - Original Registrant

Classifications
5 Pharmaceutical preparations based on human monoclonal antibodies for use in the treatment of cancer [, AIDS, acquired immune deficiency syndrome, ] and other infectious diseases, immune and autoimmune diseases, inflammatory diseases [ and cardiovascular diseases ]
1 Biochemical, namely, monoclonal antibodies for in vivo or in vitro scientific research and in vivo or in vitro development in the field of cancer [, AIDS, acquired immune deficiency syndrome, ] and other infectious diseases, immune and autoimmune diseases, inflammatory diseases [ and cardiovascular diseases ]
42 Medical scientific research, namely, biological research into human monoclonal antibodies and development of pharmaceutical products based on human monoclonal antibodies for use in the treatment of cancer, AIDS, acquired immune deficiency syndrome, and other infectious diseases, immune and autoimmune diseases, inflammatory diseases and cardiovascular diseases; chemical analysis, patent exploitation, licensing of intellectual property in the field of medicine; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy with monoclonal antibodies
Color is not claimed as a feature of the mark.

Trademark Events
May 8, 2008
Sn Assigned For Sect 66a Subseq Desig From Ib
May 9, 2008
Limitation Of Goods/Services From Ib Entered
May 12, 2008
New Application Entered
May 12, 2008
Assigned To Examiner
May 28, 2008
Approved For Pub - Principal Register
May 28, 2008
Assigned To Lie
May 29, 2008
Law Office Publication Review Completed
Jun 11, 2008
Notice Of Publication
Jul 15, 2010
Change Of Name/Address Rec'd From Ib
Jul 1, 2008
Published For Opposition
Sep 16, 2008
Registered-Principal Register
Jul 18, 2014
Teas Section 71 Received
Aug 7, 2014
Case Assigned To Post Registration Paralegal
Aug 7, 2014
Registered-Sec.71 Accepted
Aug 7, 2014
Notice Of Acceptance Of Sec. 71 - E-Mailed
Mar 20, 2015
Total Invalidation Processed By The Ib
Jun 11, 2015
International Registration Renewed
Feb 9, 2017
Change Of Name/Address Rec'd From Ib
Feb 9, 2017
New Representative At Ib Received
Apr 20, 2017
New Representative At Ib Received
Sep 8, 2017
New Representative At Ib Received
Sep 16, 2017
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Oct 26, 2017
Change Of Name/Address Rec'd From Ib
Mar 15, 2019
Teas Section 71 Received
Apr 2, 2019
Registered-Sec.71 Accepted
Apr 2, 2019
Notice Of Acceptance Of Sec. 71 - E-Mailed
Jan 3, 2020
Partial Invalidation Of Reg Ext Protection Sent To Ib
Dec 2, 2019
Partial Invalidation Of Reg Ext Protection Created
Jan 3, 2020
Invalidation Processed
Sep 19, 2023
Change Of Name/Address Rec'd From Ib
Feb 21, 2020
Partial Invalidation Processed By The Ib
Jun 5, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 5, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 5, 2024
Teas Change Of Correspondence Received
Jun 5, 2024
Teas Withdrawal As Domestic Representative Received
Jun 5, 2024
Teas Change Of Owner Address Received
Jun 5, 2024
Teas Withdrawal Of Attorney Received-Firm Retains
Jun 5, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Trademark Alertz updated from USPTO on 2030-01-24